Abstract:Neurodegenerative diseases (NDDs) have received considerable interest from scientists for a long time due to their multifactorial nature. Alzheimer's disease (AD) is of particular importance among pathologies, and despite approved drugs for its treatment, there is no effective pharmacological therapy to stop, halt, or repair neurodegeneration. The U.S. Food and Drug Administration (FDA) has approved certain medications to treat AD, including galantamine, donepezil, rivastigmine, memantine, tacrine, suvorexant, brexpiprazole, butein, and Licochalcone A. Topological indices and quantitative structure‐property relationships (QSPRs) are indispensable in drug discovery. They allow researchers to analyze, compare, and predict the properties of chemical compounds, thereby expediting the identification of promising drug candidates while minimizing experimental costs and efforts. Regression models are vital in QSPR analysis, especially when dealing with topological indices. They facilitate quantifying the relationship between chemical structure and properties, thereby facilitating drug design, material discovery, and other chemistry‐related applications. The objective of this study is to examine the efficacy of descriptors in correlating the physicochemical features of molecules associated with Alzheimer's disease. We will use the computational method to calculate degree‐related, distance‐related, and eccentricity‐based topological indices for any chemical graph. QSPR models are developed utilizing degree‐based, distance‐based, and eccentricity‐based topological indices to estimate some physicochemical properties of AD drugs, including molecular weight (MW), boiling point (BP), topological polar surface area (TPSA), complexity (C), polarizability (P), and refractive index (R). The QSPRS studies are obtained using the linear regression technique. The present study found that the topological indices Randic index R, first Zagreb index M 1 , and atom‐bond connectivity index ABC provide valuable insights into the structure‐activity relationships of different drugs and help in designing more effective combinations for treating Alzheimer's disease.

Implementation of multi-criteria decision making for the ranking of drugs used to treat bone-cancer

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

Utilizing topological indices in QSPR modeling to identify non-cancer medications with potential anti-cancer properties: a promising strategy for drug repurposing

Statistical Evaluation of Cancer Drugs by QSPR Modeling

Reverse Degree-Based Topological Indices and QSPR Analysis of Cancer Drugs

Estimating Physico-chemical Properties of Drugs for Prostate Cancer using Degree-Based and Neighbourhood Degree-Based Topological Descriptors

A Novel Drug Selection Decision Support Model Based on Real-World Medical Data by the Hybrid Entropic Weight TOPSIS Method

Topological Indices and QSPR Modeling of New Antiviral Drugs for Cancer Treatment

Topological coindices and QSPR analysis for some potential drugs used in lung cancer treatment via CoM and CoNM-polynomials

QSPR Analysis of Drugs for Treatment of Schizophrenia Using Topological Indices

The study of curve fitting models to analyze some degree-based topological indices of certain anti-cancer treatment

QSPR Analysis of Some Alzheimer's Compounds via Topological Indices and Regression Models

A python based algorithmic approach to optimize sulfonamide drugs via mathematical modeling

Uses of degree-based topological indices in QSPR analysis of alkaloids with poisonous and healthful nature

Calculation of topological indices along with MATLAB coding in QSPR analysis of calcium channel-blocking cardiac drugs

Ranking Breast Cancer Drugs and Biomarkers Identification Using Machine Learning and Pharmacogenomics

Mathematical modeling for prediction of physicochemical characteristics of cardiovascular drugs via modified reverse degree topological indices

Predictive potential of K‐Banhatti and Zagreb type molecular descriptors in structure–property relationship analysis of some novel drug molecules

Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents

QSPR Analysis of Drugs Used for Treatment of Hepatitis via Reduced Reverse Degree-Based Topological Descriptors

Scaffold-Based Multi-Objective Drug Candidate Optimization